Ultraselective Macrocycle Membranes for Pharmaceutical Ingredients Separation in Organic Solvents

We developed highly selective crown ether-based membranes for challenging separations in pharmaceutical and chemical applications. By integrating crown ethers into the polymer backbone, we enhanced the membranes' stability and selectivity for molecular separations in organic solvents.
Published in Chemistry and Sustainability
Ultraselective Macrocycle Membranes for Pharmaceutical Ingredients Separation in Organic Solvents
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

In a joint effort between Prof. Nunes and Prof. Szekely, we collaborated on a project to push the boundaries of membrane selectivity beyond what is currently available. Our groups combined expertise in membrane fabrication and performance analysis with the shared goal of developing highly selective macrocycle membranes that could handle complex separations, especially in pharmaceutical and chemical applications.

We focused on crown ethers, a class of macrocycles known for their ability to differentiate between ions and molecules. In tailoring thin-film composite membranes, crown ethers have been used as additives to enhance permselectivity in water purification and ion separations. In our approach, we integrated crown ether building blocks directly into the polymer backbone to fully utilize their unique structure. These highly selective membranes were tested in the challenging organic solvent nanofiltration (OSN) and organic solvent reverse osmosis (OSRO) applications to effectively separate drug molecules from impurities and solvents.

We employed amino-functionalized crown ethers in the aqueous phase of the interfacial polymerization reaction, forming a fully crosslinked polymer network on top of a porous support (Fig. 1). This strategy increased the macrocycle density within the film, allowing us to fully harness their selective properties. Dibenzo-18-crown-6, in particular, has a cavity size of 0.26–0.32 nm, ideal for separations in the region between OSN and OSRO.

Fig. 1. Interfacial polymerization for the fabrication of membranes. Amino-functionalized crown ether (18C6) was dissolved in the aqueous phase and contacted with polyacrylonitrile asymmetric porous support. The support was then exposed to an organic phase containing trimesoyl chloride (TMC) to react and form a polyamide selective layer.

To better understand the impact of crown ethers on the separation performance, we followed a comprehensive framework (Fig. 2). We thoroughly assessed various factors, including:

  • Material Perspective: We compared crown ether-based membranes with in-house fabricated control membranes and commercial OSN membranes. The comparison included testing membranes made from analogous polyether-based monomers (ethoxyaniline and isosorbide), which share similar chemistry with crown ethers but lack their intrinsic cavity. We also evaluated the performance of classical polyamide thin-film composite membranes and commercial OSN membranes, DuraMem®150 and GMT-oNF-2, under the same testing conditions.
  • Diverging from Standard Testing: To better simulate the complex conditions in pharmaceutical applications, we tested the membranes using a mixture containing 13 solutes with molecular weights below 850 g mol–1 and analyzed the rejection using HPLC.
  • Rejection Selectivity Analysis: We mapped size-normalized separation factors for all solute pairs using a selectivity matrix, offering valuable insight into the membranes’ selectivity beyond molecular size. We also examined the correlation between rejection selectivity and the rejection of less permeable solutes to compare the performance of different membranes. The rejection selectivity data exhibited diagonal gridlines that decreased as log(1–RB) increased. A wider distribution of data points in the x–y plane indicated a greater capacity to differentiate solutes with similar characteristics, thereby increasing the overall rejection selectivity of the membrane.

Fig. 2. Schematic framework for fabrication and performance evaluation of crown-ether based membranes. a, material selection: Included membranes synthesized from polyether-based building blocks with varying structural configurations, a classical polyamide control membrane, and commercially available OSN membranes. b, performance evaluation: Conducted using a mixture of solutes (0.25 mM each), with the rejection obtained using high-performance liquid chromatography (HPLC). c, data analysis: Estimated the rejection selectivity based on the size-normalized separation factors and mapping the results in the selectivity matrix and grid correlation to understand the separation behavior of the membranes. The crown-ether based membranes exhibited superior permselectivity performance.  

Key Findings and Implications

Comparative analysis with benchmark membranes highlighted the unique performance attributed to the macrocyclic structure of crown ethers. These membranes demonstrated both higher solvent permeance and enhanced selectivity. The acetonitrile permeance improved by 93% compared to conventional counterparts. Additionally, they showed a particularly sharp rejection profile, outperforming commercially available nanofiltration membranes by 23–90% selectivity margins.

Mapping the rejection selectivity using a mixture of structurally diverse solutes revealed that crown ether-based membranes are highly effective at retaining pharmaceutical ingredients with molecular weights around 800 g mol–1. This capability enables the efficient concentration of molecules in this size range or their purification from smaller impurities. Our research also highlighted the efficacy of membranes incorporating crown ethers in separating solute pairs with molecular weights between 100 and 370 g mol–1. The broad distribution observed on the rejection selectivity grid suggested these membranes excel at separating solutes with similar physicochemical properties. In contrast, DuraMem®150, while effective at rejecting small solutes, struggled to fractionate the mixture.

In summary, our study presents the potential of crown ether-based membranes to improve molecular separations in OSN and OSRO applications. The membranes demonstrated notable stability and selectivity for pharmaceutical ingredients. While further optimization is needed for large-scale implementation, the findings contribute to the development of selective membranes and present an interesting approach to characterizing membrane performance.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Sustainability
Research Communities > Community > Sustainability
Pharmaceutics
Physical Sciences > Chemistry > Biological Chemistry > Pharmaceutics
Separation Science
Physical Sciences > Chemistry > Analytical Chemistry > Separation Science
Supramolecular Chemistry
Physical Sciences > Chemistry > Organic Chemistry > Supramolecular Chemistry

Related Collections

With collections, you can get published faster and increase your visibility.

Biology of rare genetic disorders

This cross-journal Collection between Nature Communications, Communications Biology, npj Genomic Medicine and Scientific Reports brings together research articles that provide new insights into the biology of rare genetic disorders, also known as Mendelian or monogenic disorders.

Publishing Model: Open Access

Deadline: Oct 30, 2024

Advances in catalytic hydrogen evolution

This collection encourages submissions related to hydrogen evolution catalysis, particularly where hydrogen gas is the primary product. This is a cross-journal partnership between the Energy Materials team at Nature Communications with Communications Chemistry, Communications Engineering, Communications Materials, and Scientific Reports. We seek studies covering a range of perspectives including materials design & development, catalytic performance, or underlying mechanistic understanding. Other works focused on potential applications and large-scale demonstration of hydrogen evolution are also welcome.

Publishing Model: Open Access

Deadline: Dec 31, 2024